Synopsis
Synopsis
0
CEP/COS
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Urapidil Hcl
2. 64887-14-5
3. Urapidil (hydrochloride)
4. Pvu92pzo12
5. Ncgc00094502-01
6. Ebrantil (tn)
7. Dsstox_cid_25812
8. Dsstox_rid_81149
9. Dsstox_gsid_45812
10. 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione;hydrochloride
11. 6-((3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethylpyrimidine-2,4(1h,3h)-dione Hydrochloride
12. 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1h,3h)-pyrimidinedione Monohydrochloride
13. Smr000058525
14. Sr-01000075295
15. Cas-64887-14-5
16. Unii-pvu92pzo12
17. Urapidilhydrochloride
18. Urapidil Hydrochloride,(s)
19. Urapidil Hydrochloride, Solid
20. Mls000758309
21. Mls001424033
22. C20h29n5o3.hcl
23. Schembl1321654
24. Chembl1256716
25. Dtxsid2045812
26. Hy-b0354a
27. Hms1570f12
28. Pharmakon1600-01503100
29. Bcp23389
30. Tox21_111286
31. Tox21_501265
32. Mfcd00078601
33. Nsc758226
34. S2025
35. Akos015994621
36. Tox21_111286_1
37. Ac-8089
38. Ccg-100798
39. H61u751
40. Hs-0064
41. Lp01265
42. Nc00048
43. Nsc-758226
44. Urapidil Hydrochloride [who-dd]
45. Ncgc00016066-14
46. Ncgc00261950-01
47. Eu-0101265
48. Ft-0675734
49. Sw197244-4
50. U-100
51. C76033
52. D08662
53. Sr-01000075295-1
54. Sr-01000075295-3
55. Sr-01000075295-9
56. Q27286781
57. Sr-01000075295-10
58. 6[[3-[4-(o-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil Hydrochloride
59. 2,4(1h,3h)-pyrimidinedione, 6-((3-(4-(2-methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl-, Monohydrochloride
60. 6-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propylamino)-1,3-dimethylpyrimidine-2,4(1h,3h)-dione Hydrochloride
61. 6-[[3-[4-(2-methoxyphenyl)-1-pipera Zinyl]propyl]amino]-1,3-dimethyl-2,4(1h,3h)-pyrimi Dinedione Hydrochloride
62. 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1h,3h)-pyrimidinedione Hydrochloride
Molecular Weight | 423.9 g/mol |
---|---|
Molecular Formula | C20H30ClN5O3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 7 |
Exact Mass | 423.2037175 g/mol |
Monoisotopic Mass | 423.2037175 g/mol |
Topological Polar Surface Area | 68.4 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 588 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Date of Issue : 2025-02-27
Valid Till : 2028-02-26
Written Confirmation Number : WC-0511
Address of the Firm :
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Date of Issue : 2025-02-27
Valid Till : 2028-02-26
Written Confirmation Number : WC-511n
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38214
Submission : 2023-03-29
Status : Active
Type : II
NDC Package Code : 81666-004
Start Marketing Date : 2023-03-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4382
Submission : 1981-12-07
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Registration Number : 304MF10127
Registrant's Address : VIA F. BARACCA 19-24060 SAN PAOLO D'ARGON (BERGAMO) ITALY
Initial Date of Registration : 2022-08-31
Latest Date of Registration :
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2020-06-24
Registration Number : 20200624-211-J-564
Manufacturer Name : Erregierre SpA
Manufacturer Address : Via Francesco. Baracca, 19-24060 SAN PAOLO D'ARGON (BG), Italy
Date of Issue : 2022-06-15
Valid Till : 2025-07-07
Written Confirmation Number : WC-0204
Address of the Firm :
Date of Issue : 2022-06-15
Valid Till : 2025-07-07
Written Confirmation Number : WC-0204
Address of the Firm :
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Date of Issue : 2025-02-27
Valid Till : 2028-02-26
Written Confirmation Number : WC-511n
Address of the Firm : Plot No. 80A, Road No.5, Jawaharlal Nehru Pharma City, E. Bonangi (V), Parawada ...
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Date of Issue : 2025-02-27
Valid Till : 2028-02-26
Written Confirmation Number : WC-0511
Address of the Firm : Plot No. 80A, Road No.5, Jawaharlal Nehru Pharma City, E. Bonangi (V), Parawada ...
Date of Issue : 2022-06-15
Valid Till : 2025-07-07
Written Confirmation Number : WC-0204
Address of the Firm : C-4, MIDC, Village Pawne, Thane Belapur Road, Vashi, Navi Mumbai ? 400 703
Date of Issue : 2022-06-15
Valid Till : 2025-07-07
Written Confirmation Number : WC-0204
Address of the Firm : C-4, MIDC, Village Pawne, Thane Belapur Road, Vashi, Navi Mumbai ? 400 703
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
About the Company : Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-appro...
About the Company : Beijing Fukangren Biopharmaceutical Technology Co., Ltd. started its drug R&D service in 1999 and is the CRO company with the longest continuous service time in China. Fukangren no...
About the Company : ERREGIERRE, a family company, was founded in 1974 and today is one of the leading Italian active pharmaceutical ingredients manufactures for human and veterinary use. In ERREGIE...
About the Company : Hebei AiYoung Pharmaceutical Technology Co., Ltd. is a professional company mainly engaged in chemical APIs and intermediates, including R & D, production, import and export. The c...
About the Company : Hiray Pharma Solutions is an international end-to-end CDMO, facilitating the development and manufacturing of important drug products and key intermediates around the world. We pro...
About the Company : Mangalmurti Bio-Chem Private Limited was established in 2010, initially focusing on the production of NPK fertilizer blends with a daily capacity of 200 tons. The company successfu...
About the Company : We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (...
About the Company : Established in 1999, Hankang Pharmaceutical Group stands as a prominent CRO-CDMO integrated service enterprise in China. Focused on generic drugs while venturing into innovative on...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
The portfolio to be divested to Hasten includes cardiovascular and metabolism products sold in mainland China which includes Ebrantil®.
Lead Product(s): Urapidil Hydrochloride
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Ebrantil
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Hasten Biopharmaceutic
Deal Size: $322.0 million Upfront Cash: Undisclosed
Deal Type: Divestment December 21, 2020
Lead Product(s) : Urapidil Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Hasten Biopharmaceutic
Deal Size : $322.0 million
Deal Type : Divestment
Details : The portfolio to be divested to Hasten includes cardiovascular and metabolism products sold in mainland China which includes Ebrantil®.
Product Name : Ebrantil
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
December 21, 2020
1-(2-Methoxyphenyl)piperazine Base
CAS Number : 35386-24-4
End Use API : Urapidil Hydrochloride
About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...
1-(2-Methoxyphenyl)piperazine HCl
CAS Number : 5464-78-8
End Use API : Urapidil Hydrochloride
About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...
CAS Number : 6972-27-6
End Use API : Urapidil Hydrochloride
About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...
1-(2-METHOXY PHENYL)PIPERAZINE HCL
CAS Number : 5464-78-8
End Use API : Urapidil Hydrochloride
About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...
CAS Number : 6642-31-5
End Use API : Urapidil Hydrochloride
About The Company : The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufacture of high-quality Active Pharmaceutical Ingredients (AP...
CAS Number : 6972-27-6
End Use API : Urapidil Hydrochloride
About The Company : The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufacture of high-quality Active Pharmaceutical Ingredients (AP...
1,3-Dimethyl-6-(3-chloro aminopropyl) uracil
CAS Number : 34654-81-4
End Use API : Urapidil Hydrochloride
About The Company : The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufacture of high-quality Active Pharmaceutical Ingredients (AP...
1-(2-Methoxyphenyl)piperazine hydrochloride
CAS Number : 5464-78-8
End Use API : Urapidil Hydrochloride
About The Company : Integrin Life Sciences Pvt. Ltd. is one of the growing pharmaceutical API, advanced chemical intermediates manufacturing companies in India. Our Plant is Locate...
6-[(3-Chloropropyl)amino]-1,3-dimethyluracil
CAS Number : 34654-81-4
End Use API : Urapidil Hydrochloride
About The Company : Integrin Life Sciences Pvt. Ltd. is one of the growing pharmaceutical API, advanced chemical intermediates manufacturing companies in India. Our Plant is Locate...
CAS Number : 6972-27-6
End Use API : Urapidil Hydrochloride
About The Company : The division was established in 1981 as a Specialty Chemicals Division with a focus to manufacture specialty chemicals and pharmaceutical intermediates. In Apri...
Regulatory Info :
Registration Country : Italy
Brand Name : Urasap
Dosage Form : Urapidil 50Mg 10Ml 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV 10 ml 50 mg/10 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Urapidil
Dosage Form : Urapidil 50Mg 10Ml 5 Units Parenteral Use
Dosage Strength : 5 EV vials 50 mg 10 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ebrantil
Dosage Form : Urapidil 50Mg 10Ml 5 Units Parenteral Use
Dosage Strength : 5 EV vials 50 mg 10 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info :
Registration Country : Austria
Brand Name : Tachyben
Dosage Form : Solution for Injection
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Austria
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Packaging :
Regulatory Info :
Dosage : Solution for Injection
Dosage Strength : 50MG
Brand Name : Tachyben
Approval Date :
Application Number :
Registration Country : Austria
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info :
Registration Country : Austria
Brand Name : Tachyben
Dosage Form : Solution for Injection
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Austria
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Packaging :
Regulatory Info :
Dosage : Solution for Injection
Dosage Strength : 25MG
Brand Name : Tachyben
Approval Date :
Application Number :
Registration Country : Austria
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info :
Registration Country : Austria
Brand Name : Tachyben
Dosage Form : Solution for Injection
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Austria
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Packaging :
Regulatory Info :
Dosage : Solution for Injection
Dosage Strength : 100MG
Brand Name : Tachyben
Approval Date :
Application Number :
Registration Country : Austria
Regulatory Info :
Registration Country : Turkey
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 25MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging :
Regulatory Info :
Dosage : Solution for Injection
Dosage Strength : 25MG/5ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Capsule
Dosage Strength : 60MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country :
Brand Name :
Dosage Form : Prolonged Release Caps...
Dosage Strength : 30MG
Packaging : 30, 50, 60 (2x 30),90 (3x 30) and 100 (2x 50) capsules
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
Packaging : 30, 50, 60 (2x 30),90 (3x 30) and 100 (2x 50) capsules
Regulatory Info :
Dosage : Prolonged Release Caps...
Dosage Strength : 30MG
Brand Name :
Approval Date :
Application Number :
Registration Country :
Regulatory Info :
Registration Country :
Brand Name :
Dosage Form : Prolonged Release Caps...
Dosage Strength : 90MG
Packaging : 30, 50, 60 (2x 30),90 (3x 30) and 100 (2x 50) capsules
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
Packaging : 30, 50, 60 (2x 30),90 (3x 30) and 100 (2x 50) capsules
Regulatory Info :
Dosage : Prolonged Release Caps...
Dosage Strength : 90MG
Brand Name :
Approval Date :
Application Number :
Registration Country :
Regulatory Info :
Registration Country :
Brand Name :
Dosage Form : Solution for Injection...
Dosage Strength : 5MG/ML
Packaging : 5 ml, 10 ml and 20 ml in glass ampoule; 5 ampoules
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
Packaging : 5 ml, 10 ml and 20 ml in glass ampoule; 5 ampoules
Regulatory Info :
Dosage : Solution for Injection...
Dosage Strength : 5MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country :
Regulatory Info :
Registration Country : France
Brand Name :
Dosage Form : Capsule
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Packaging :
Regulatory Info :
Dosage : Capsule
Dosage Strength : 30MG
Brand Name :
Approval Date :
Application Number :
Registration Country : France
Regulatory Info :
Registration Country : France
Brand Name :
Dosage Form : Capsule
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Packaging :
Regulatory Info :
Dosage : Capsule
Dosage Strength : 60MG
Brand Name :
Approval Date :
Application Number :
Registration Country : France
Global Sales Information
Market Place
Reply
17 Nov 2020
REF. STANDARDS & IMPURITIES
CAS Number : 34661-73-9
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : U0005.06
ABOUT THIS PAGE
53
PharmaCompass offers a list of Urapidil Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Urapidil Hydrochloride manufacturer or Urapidil Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Urapidil Hydrochloride manufacturer or Urapidil Hydrochloride supplier.
PharmaCompass also assists you with knowing the Urapidil Hydrochloride API Price utilized in the formulation of products. Urapidil Hydrochloride API Price is not always fixed or binding as the Urapidil Hydrochloride Price is obtained through a variety of data sources. The Urapidil Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Uraprene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Uraprene, including repackagers and relabelers. The FDA regulates Uraprene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Uraprene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Uraprene manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Uraprene supplier is an individual or a company that provides Uraprene active pharmaceutical ingredient (API) or Uraprene finished formulations upon request. The Uraprene suppliers may include Uraprene API manufacturers, exporters, distributors and traders.
click here to find a list of Uraprene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Uraprene DMF (Drug Master File) is a document detailing the whole manufacturing process of Uraprene active pharmaceutical ingredient (API) in detail. Different forms of Uraprene DMFs exist exist since differing nations have different regulations, such as Uraprene USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Uraprene DMF submitted to regulatory agencies in the US is known as a USDMF. Uraprene USDMF includes data on Uraprene's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Uraprene USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Uraprene suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Uraprene Drug Master File in Japan (Uraprene JDMF) empowers Uraprene API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Uraprene JDMF during the approval evaluation for pharmaceutical products. At the time of Uraprene JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Uraprene suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Uraprene Drug Master File in Korea (Uraprene KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Uraprene. The MFDS reviews the Uraprene KDMF as part of the drug registration process and uses the information provided in the Uraprene KDMF to evaluate the safety and efficacy of the drug.
After submitting a Uraprene KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Uraprene API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Uraprene suppliers with KDMF on PharmaCompass.
A Uraprene written confirmation (Uraprene WC) is an official document issued by a regulatory agency to a Uraprene manufacturer, verifying that the manufacturing facility of a Uraprene active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Uraprene APIs or Uraprene finished pharmaceutical products to another nation, regulatory agencies frequently require a Uraprene WC (written confirmation) as part of the regulatory process.
click here to find a list of Uraprene suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Uraprene as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Uraprene API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Uraprene as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Uraprene and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Uraprene NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Uraprene suppliers with NDC on PharmaCompass.
Uraprene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Uraprene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Uraprene GMP manufacturer or Uraprene GMP API supplier for your needs.
A Uraprene CoA (Certificate of Analysis) is a formal document that attests to Uraprene's compliance with Uraprene specifications and serves as a tool for batch-level quality control.
Uraprene CoA mostly includes findings from lab analyses of a specific batch. For each Uraprene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Uraprene may be tested according to a variety of international standards, such as European Pharmacopoeia (Uraprene EP), Uraprene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Uraprene USP).